TY - JOUR
T1 - Pathological roles of iron in cardiovascular disease
AU - Kobayashi, Motoi
AU - Suhara, Tomohiro
AU - Baba, Yuichi
AU - Kawasaki, Nicholas K.
AU - Higa, Jason K.
AU - Matsui, Takashi
N1 - Funding Information:
This work was supported in part by a research grant from Japan Heart Foundation, Japan (M. Kobayashi), the Mitsu-koshi Health and Welfare Foundation, Japan (T. Suhara), a research grant from Kochi Organization for Medical Reformation and Renewal, Japan (Y. Baba) and NIH grants (P30GM103341 and P20 GM113134 to TM).
Publisher Copyright:
© 2018 Bentham Science Publishers.
PY - 2018
Y1 - 2018
N2 - Iron is an essential mineral required for a variety of vital biological functions. Despite being vital for life, iron also has potentially toxic aspects. Iron has been investigated as a risk factor for coronary artery disease (CAD), however, iron’s toxicity in CAD patients still remains controversial. One possible mechanism behind the toxicity of iron is “ferroptosis”, a newly described form of iron-dependent cell death. Ferroptosis is an iron-dependent form of regulated cell death that is distinct from apoptosis, necroptosis, and other types of cell death. Ferroptosis has been reported in ischemia-reperfusion (I/R) injury and several other diseases. Recently, we reported that ferroptosis is a significant form of cell death in cardiomyocytes. Moreover, myocardial hemorrhage, a major event in the pathogenesis of heart failure, could trigger the release of free iron into cardiac muscle and is an independent predictor of adverse left ventricular remodeling after myocardial infarction. Iron deposition in the heart can now be detected with advanced imaging methods, such as T2 star (T2*) cardiac magnetic resonance imaging, which can non-invasively predict iron levels in the myocardium and detect myocardial hemorrhage, thus existing technology could be used to assess myocardial iron. We will discuss the role of iron in cardiovascular diseases and especially with regard to myocardial I/R injury.
AB - Iron is an essential mineral required for a variety of vital biological functions. Despite being vital for life, iron also has potentially toxic aspects. Iron has been investigated as a risk factor for coronary artery disease (CAD), however, iron’s toxicity in CAD patients still remains controversial. One possible mechanism behind the toxicity of iron is “ferroptosis”, a newly described form of iron-dependent cell death. Ferroptosis is an iron-dependent form of regulated cell death that is distinct from apoptosis, necroptosis, and other types of cell death. Ferroptosis has been reported in ischemia-reperfusion (I/R) injury and several other diseases. Recently, we reported that ferroptosis is a significant form of cell death in cardiomyocytes. Moreover, myocardial hemorrhage, a major event in the pathogenesis of heart failure, could trigger the release of free iron into cardiac muscle and is an independent predictor of adverse left ventricular remodeling after myocardial infarction. Iron deposition in the heart can now be detected with advanced imaging methods, such as T2 star (T2*) cardiac magnetic resonance imaging, which can non-invasively predict iron levels in the myocardium and detect myocardial hemorrhage, thus existing technology could be used to assess myocardial iron. We will discuss the role of iron in cardiovascular diseases and especially with regard to myocardial I/R injury.
KW - Ferroptosis
KW - Iron
KW - Ischemia-reperfusion injury
KW - Myocardial infarction
KW - Reactive oxygen species
UR - http://www.scopus.com/inward/record.url?scp=85061021645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061021645&partnerID=8YFLogxK
U2 - 10.2174/1389450119666180605112235
DO - 10.2174/1389450119666180605112235
M3 - Review article
C2 - 29874997
AN - SCOPUS:85061021645
SN - 1389-4501
VL - 19
SP - 1068
EP - 1076
JO - Current drug targets
JF - Current drug targets
IS - 9
ER -